Keywords: American Capital, Cambridge Major Laboratories, M&A, APIs, Development, Manufacturing
American Capital commits $212 million to acquire Cambridge Major Laboratories
Article | 03 January 2013
Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout of USA-based Cambridge Major ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
